Recent Events
Learn how Herophilus optimizes the scaling of patient-derived brain organoids to uncover deep phenotypes of disease in our latest bioRxiv preprint.
Herophilus CTO Doug Flanzer discusses AWS technology and its role in our neurotherapeutics discovery pipeline at AWS HCLS 2020.
Herophilus Co-Founder Sean Escola speaks about our mission at Brain Mind 2019.
In the News
email: press {at} herohpilus {dot} com
WALL STREET JOURNAL – SEPTEMBER 12, 2018
Startup Uses ‘Mini Brains’ and Software to Power Drug Research
SERIES A PRESS RELEASE – SEPTEMBER 12, 2018
System1 announces Series A funding, led by Pfizer Ventures and Charles River Ventures